Analyst Ratings for Emergent Biosolutions Inc. (EBS)

Updated: 2017-07-27

Analysts covering Emergent Biosolutions Inc. (NYSE:EBS) have given it a consensus rating of Buy. A consensus rating of Buy was previously issued for EBS last month.

A buy rating was issued by 5 analysts, 0 gave an overweight rating, 1 gave a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

A number of analysts gave price targets for EBS. The most optimistic analyst gave a price target of 50, implying a possible profit of 38.7 percent. The minimum price target given was 33, implying potential capital losses of -8.46 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. The average change in earnings estimates over the last 90 days is -33.43 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of 4.29 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts made negative revisions. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.

The growth rate of EBS's earnings is estimated by analysts to be 27.19 percent. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. Investors like to see smaller values for the PEG ratio, because people typically see that as an indicator of higher growth relative to stock price. Wall Street investors typically prefer a PEG ratio to be smaller than 1, although it is frequently more appropriate to compare PEG ratios to the company's peers. The PEG ratio of EBS is 1.11.

In the trailing 52-weeks, EBS hit 36.64 at the highest peak, while it's lowest trading point was 24.47. The current market price is above the trailing year's low by 47.32 percent, and below the high by 1.61 percent. EBS has a price/earnings ratio of 30.31. Investors typically compare the P/E ratio to a company's peers in the industry. The EBS value stock report compares EBS to some of its peers using value stock charts. The stock has a market capitalization of $1.48 billion. EBS is estimated to release their earnings results for the quarter on 0000-00-00, days from today.